Clinical Trial Update: A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating inhaled Fexlamose for adults with moderate to severe chronic obstructive pulmonary disease. The study is currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fexlamose (Fexlamose)

Snippet

Sponsor: Aer Therapeutics | Conditions: COPD | Phase 2 | Status: NOT_YET_RECRUITING